Logo
Login
$VOR
$18.33 +$0.07 (0.38%) Close

Company Executives

$VOR Management Team

Dr. Jean-Paul Kress

Chairman of the Board

Chief Executive Officer

Age 60
Compensation -
Sex Male

Mr. Sandesh Mahatme

Chief Financial Officer

Chief Business Officer

Age 60
Compensation -
Sex Male

Mr. Dallan Murray

Chief Commercial Officer

Age 55
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Apr 27, 2026
Directors
8
serving now
Independent
6 of 7
stated in the proxy; 1 not stated
Average tenure
1.8 years
from year joined
CEO also chairs the board
Yes
Jean-Paul Kress
Director Age On board Independent Committees Other public boards 2025 pay Source
Fouad Namouni
57 2024
2 years
 Independent
Compensation Nominating and Corporate Governance · Chair
None stated $51,089
Andrew Levin
49 2025
1 year
 Independent None stated None stated $31,881
Erez Kalir
54 2025
1 year
 Independent
Audit
None stated $123,033
Wouter Joustra
37 2025
1 year
 Not stated None stated NewAmsterdam Pharma N.V. $31,881
Jean-Paul Kress
Board chair, CEO
 60 2025
1 year
 Not independent None stated None stated Paid as CEO
Daniella Beckman
Lead independent director
 47 2020
6 years
 Independent
Audit · Chair Compensation
Upstream Bio $64,200
Alexander (Bo) Cumbo
55 2025
1 year
 Independent
Compensation · Chair Nominating and Corporate Governance
None stated $121,365
Michel Detheux
59 2025
1 year
 Independent
Audit
None stated $119,350

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans